Hofseth BioCare ASA (LON:0Q6H)
2.380
+0.430 (22.05%)
At close: May 13, 2025
Hofseth BioCare ASA Revenue
Hofseth BioCare ASA had revenue of 60.86M NOK in the quarter ending March 31, 2025, with 16.24% growth. This brings the company's revenue in the last twelve months to 274.04M, up 21.20% year-over-year. In the year 2024, Hofseth BioCare ASA had annual revenue of 265.54M with 21.52% growth.
Revenue (ttm)
274.04M NOK
Revenue Growth
+21.20%
P/S Ratio
2.88
Revenue / Employee
3.51M NOK
Employees
78
Market Cap
58.08M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 265.54M | 47.03M | 21.52% |
Dec 31, 2023 | 218.51M | 98.06M | 81.42% |
Dec 31, 2022 | 120.45M | 32.83M | 37.47% |
Dec 31, 2021 | 87.62M | 18.36M | 26.52% |
Dec 31, 2020 | 69.25M | 1.47M | 2.17% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
HSBC Holdings | 44.89B |
Shell | 217.54B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |
RELX PLC | 9.43B |
Rio Tinto Group | 42.86B |